OmniComm provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organisations that conduct life changing clinical trial research.
AE Reporting is an advanced adverse event reporting and information management system designed for the global collection, assessment, reporting, and analysis of clinical trial and post-marketing adverse events.
The functionality within AE Reporting will automate many of the complex activities associated with drug safety, including data entry, medical review, reporting and case distribution.
Beardsworth president and CEO Michael Brien said that they are happy to incorporate OmniComm’s AE Reporting System to broaden their ability in safety reporting, which is an essential element in the services to their clients.
OmniComm Systems president and COO Stephen Johnson said that they are extremely pleased that Beardsworth has selected AE Reporting to be part of its global safety surveillance practice and they are committed to providing leading solutions and services across the eClinical spectrum to aid their clients with their complex clinical research needs.
